Translate this page into:
Usefulness of single photon emission computed tomography (SPECT)/computed tomography and radioguided surgery in a patient with recurrent pheochromocytoma
Address for correspondence: Dr. Jon Andoni Uña-Gorospe, Department of Nuclear Medicine, Hospital Universitario Nuestra Señora de Candelaria, Carretera del Rosario 145, 38010 Santa Cruz de Tenerife, Spain. E-mail: junagor@gobiernodecanarias.org
This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
This article was originally published by Medknow Publications & Media Pvt Ltd and was migrated to Scientific Scholar after the change of Publisher.
Sir,
Pheochromocytoma and neuroblastoma are the most common tumors originating from the adrenergic nervous system. Localitation of pheochromocytoma is based mostly on computed tomography (CT), magnetic resonance imaging (MRI), and radio iodinated meta-iodobenzyl-guanidine (MIBG). MIBG scintigraphy contributes mainly to the delineation of extra-adrenal disease and metastatic spread.[1] We present an 11-year-old child with refractory hypertension diagnosed of having pheocromocytoma who underwent bilateral adrenalectomy. During follow-up, 4 years after the surgery, urinary nor-metanenephrine level rose to 365 μg/24 h (normal value: 0-354 μg/24 h). An I-123 MIBG scintigraphy showed focal uptake of radiotracer in the abdomen that increased in the delayed image (24 h). Single photon emission computed tomography/Computed tomography (SPECT/CT) localized the focal uptake in a node, measuring 14 mm × 8 mm in size, located between the superior mesenteric artery and the uncinate process of the pancreas, above the aorta [Figure 1] suggesting disease recurrence.

Due to the difficulty in the surgical approach secondary to previous surgery, gamma probe guided excision as described previously[2345] was planned collectively by the Pediatric Surgery and Nuclear Medicine Departments. The day before the surgery, 144 MBq of I-123 MIBG was administered intravenously. Planar and SPECT images were acquired to check the actual size of the nodule. Next day radio-guided excision of the lesion was done by a right subcostal incision over the previous surgical scar. A fixed mass over the artery were removed. The gamma probe confirmed that the lesion was totally removed. The count rates on the gamma probe was 470 cps in in-vivo node, 503 cps in ex-vivo node, 170 cps over liver and 70 cps in the surgical bed after excision [Figure 2]. The excised mass revealed paraganglioma on histopatological examination.

Post-surgical period was uneventful. Urinary metanephrine levels were normal. Repetead I-123 MIBG scintigraphy 6 months later did not show any pathological uptake [Figure 3].

To the best of our knowledge, this is the first case wich surgical treatment was done based on the radio guided location using a gamma probe. This demonstrates that how a multidisciplinary approach helps in the patient's management making the surgery easier and diminishing morbidity.
REFERENCES
- 111In-pentetreotide and 123I-MIBG for detection and resection of lymph node metastases of a carcinoid not visualized by CT, MRI or FDG-PET. Ann Nucl Med. 2005;19:611-5.
- [Google Scholar]
- Intraoperative search for neuroblastoma by MIBG and radioguided surgery with the gamma detector. Med Pediatr Oncol. 1997;28:171-4.
- [Google Scholar]
- Iodine 123 metaiodobenzylguanidine radio-guided navigation surgery for recurrent medullary thyroid carcinoma in a girl with multiple endocrine neoplasia type 2B. J Pediatr Surg. 2005;40:1643-6.
- [Google Scholar]
- Residual lymph node metastasis in stage 4 neuroblastoma – Advantage of radio-guided surgery? Pediatr Hematol Oncol. 2010;27:471-5.
- [Google Scholar]